Suchergebnisse - "Fragkaki, Argyro"

PubPharm (19)

1

New long-standing metabolites of 17α-methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine

enthalten in: Drug testing and analysis | 2024

von Angelis, Y. | Sakellariou, P. | Fragkaki, A. | +8

2

New long‐standing metabolites of 17α‐methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine

enthalten in: Drug Testing and Analysis | 2024

von Angelis, Y. | Sakellariou, P. | Fragkaki, A. | +8

3

LC-MS/(MS) confirmatory doping control analysis of intact phase II metabolites of methenolone and mesterolone after Girard's Reagent T derivatization

enthalten in: Drug testing and analysis | 2023

von Angelis, Y. | Fragkaki, A. | Kiousi, P. | +2

4

Identifying risk management challenges in laboratories

enthalten in: Accreditation and quality assurance | 2023

von Tziakou, E. | Fragkaki, A. | Platis, A.

5

Identifying risk management challenges in laboratories

enthalten in: Accreditation and quality assurance | 2023

von Tziakou, E. | Fragkaki, A. | Platis, A.

6

LC‐MS/(MS) confirmatory doping control analysis of intact phase II metabolites of methenolone and mesterolone after Girard's Reagent T derivatization

enthalten in: Drug Testing and Analysis | 2023

von Angelis, Y. | Fragkaki, A. | Kiousi, P. | +2

7

Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes

enthalten in: Drug testing and analysis | 2021

von Kiousi, P. | Fragkaki, A. | Kioukia-Fougia, N. | +1

8

Determination of salmeterol, α-hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC-QTOF-MS

enthalten in: Biomedical chromatography : BMC | 2021

von Sakellariou, P. | Petrou, M. | Lyris, E. | +5

9

Determination of salmeterol,α‐hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC–QTOF–MS

enthalten in: Biomedical Chromatography | 2021

von Sakellariou, P. | Petrou, M. | Lyris, E. | +5

10

Liquid chromatography–mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes

enthalten in: Drug Testing and Analysis | 2021

von Kiousi, P. | Fragkaki, A. | Kioukia‐Fougia, N. | +1